Research into attitudes towards starting treatment early

The H-TEAM’s research aimed to gain insight into the perceptions of, as well as the motivating and demotivating factors for, starting treatment early (in case of a CD4 count of over 500) among people living with HIV and HIV practitioners.
snelstarten

What research methods were used?

The research comprised interviews with thirteen HIV-positive patients – who had a CD4 count over 500 cells/m3 at the moment of diagnosis – and sixteen HIV practitioners, among whom nine internist-infectious diseases specialists and seven HIV counsellors. The intention was to investigate a group of participants which was as diverse as possible (in terms of gender, age, ethnicity and attitude towards early starting) to give a broad overview of the factors that play a role in the decision-making process of starting treatment early or not.

Aim of the research

The H-TEAM’s research aimed to gain insight into the perceptions of, as well as the motivating and demotivating factors for, starting treatment early (in case of a CD4 count of over 500) among people living with HIV and HIV practitioners.

waarom-w

Why this investigation?

The potential advantages of starting antiretroviral therapy (ART) early – such as the prevention of health loss and virus transmissions – are largely determined by the willingness of HIV patients and HIV practitioners (to advise) to start treatment in case of a high CD4 count

Read more >>

aanpakken

What research methods were used?

The research comprised interviews with thirteen HIV-positive patients – who had a CD4 count over 500 cells/m3 at the moment of diagnosis – and sixteen HIV practitioners, among whom nine internist-infectious diseases specialists and seven HIV counsellors.

Read more >>

resultaat-w

Research results:

The majority of practitioners and patients appeared to feel positive about early treatment, and they quickly started treatment (or advised their patients to do so). The ideas and decision-making processes related to early treatment were influenced by treatment-related factors and patient-related factors.

Read more >>

Team

  • Anne van Puffelen
    Anne van Puffelen

    Member
    AIGHD

  • Marijn de Bruin
    Marijn de Bruin

    Member
    UvA

  • Suzanne Geerlings
    Suzanne Geerlings

    Project Leader
    Amsterdam UMC

  • Jan Prins
    Jan Prins

    Project Leader
    Amsterdam UMC